Table 4.

The effects of Total Clinician Administered PTSD Scale (CAPS) Severity Score Change from Baseline to Each Follow-up Timepoint on the Maximum Number of Days of Use Across 10 Drug Categories by Treatment Group (N=353)

	Adjusted Odds	95% Confidence
Covariates^a	Ratio	Interval	df	χ²
Seeking Safety			2	8.45^*
Abstinent	1.00	0.97–1.03
Light Users	1.01	1.00–1.03
Heavy Users	1.05^***	1.03–1.07
Women’s Health Education			2	2.97
Abstinent	1.01	0.99–1.02
Light Users^b	1.02^*	1.01–1.04
Heavy Users	1.01	0.99–1.02

Model adjusted by site, age, race/ethnicity, education, marital status, and all follow up timepoints.

There was a significant relationship between CAPS change and substance use outcome among light users in the Women’s Health Education group, however, there was no difference between Women’s Health Education substance use categories, as indicated by the non-significant chi-square statistic displayed in the table.

p < 0.05,

^**

p < 0.01,

^***

p < 0.001